Sec. 1021. NIH research strategic plan
628 words·~3 min read·
/bill/114/hr/6/rh/section-1021A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 402 of the Public Health Service Act ( 42 U.S.C. 282 ) is amended— in subsection (b), by amending paragraph
(5)to read as follows: shall ensure that scientifically based strategic planning is implemented in support of research priorities as determined by the agencies of the National Institutes of Health, including through development, use, and updating of the research strategic plan under subsection (m); ; and by adding at the end the following: For each successive five-year period beginning with the period of fiscal years 2016 through 2020, the Director of NIH, in consultation with the entities described in subparagraph (B), shall develop and maintain a biomedical research strategic plan that— is designed to increase the efficient and effective focus of biomedical research in a manner that leverages the best scientific opportunities through a deliberative planning process; identifies areas, to be known as strategic focus areas, in which the resources of the National Institutes of Health can best contribute to the goal of expanding knowledge on human health in the United States through biomedical research; and includes objectives for each such strategic focus area. The entities described in this subparagraph are the directors of the national research institutes and national centers, researchers, patient advocacy groups, and industry leaders. The Director of NIH and the directors of the national research institutes and national centers shall use the strategic plan— to identify research opportunities; and to develop individual strategic plans for the research activities of each of the national research institutes and national centers that— have a common template; and identify strategic focus areas in which the resources of the national research institutes and national centers can best contribute to the goal of expanding knowledge on human health in the United States through biomedical research. The strategic focus areas identified pursuant to paragraph (1)(A)(ii) shall— be identified in a manner that— considers the return on investment to the United States public through the investments of the National Institutes of Health in biomedical research; and contributes to expanding knowledge to improve the United States public’s health through biomedical research; and include overarching and trans-National Institutes of Health strategic focus areas, to be known as Mission Priority Focus Areas, which best serve the goals of preventing or eliminating the burden of a disease or condition and scientifically merit enhanced and focused research over the next 5 years. In developing and maintaining a strategic plan under this subsection, the Director of NIH shall ensure that rare and pediatric diseases and conditions remain a priority. In developing and maintaining a strategic plan under this subsection, the Director of NIH shall ensure that maintaining the biomedical workforce of the future, including the participation by scientists from groups traditionally underrepresented in the scientific workforce, remains a priority. Not later than 270 days after the date of enactment of this subsection, the Director of NIH and the directors of the national research institutes and national centers shall— complete the initial strategic plan required by paragraphs
(1)and (2); and make such initial strategic plan publicly available on the website of the National Institutes of Health. Not less than annually, the Director of NIH, in consultation with the directors of the national research institutes and national centers, shall conduct progress reviews for each strategic focus area identified under paragraph (1)(A)(ii). Not later than the end of the 5-year period covered by the initial strategic plan under this subsection, and every 5 years thereafter, the Director of NIH, in consultation with the directors of the national research institutes and national centers, stakeholders in the scientific field, advocates, and the public at large, shall— conduct a review of the plan, including each strategic focus area identified under paragraph (2)(B); and update such plan in accordance with this section. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 1021
NIH research strategic plan
Cites 1Cited by 0 across 0 sources